Sanofi, Sanofi-Aventis • 20 Stück
Migralgin
Product Insights
Migralgin is an over-the-counter analgesic tablet from Sanofi marketed in the Czech Republic for the relief of migraine and other moderate pain. Its formulation combines 500 mg of paracetamol, 65 mg of caffeine and 30 mg of codeine, delivering rapid pain relief while the caffeine boosts the analgesic effect. Because it contains codeine, the product requires careful dosing, may cause drowsiness, constipation or dependence, and should be avoided by individuals with opioid sensitivity, liver disease, or who are pregnant.
Comparative Analysis
Migralgin occupies a niche in the Czech over-the-counter analgesic market as a fast-acting migraine relief tablet combining paracetamol, caffeine and low-dose codeine, differentiating itself from plain acetaminophen products by offering enhanced pain control at the cost of opioid-related precautions.
Unlock Full Product Insights
Scan this and millions of other daily products to reveal hidden ingredients, safety alerts, and comprehensive analysis with the free NutrScan app.
Frequently Asked Questions
Everything you need to know about Migralgin.
